Antje Wick

12.1k total citations · 3 hit papers
87 papers, 4.6k citations indexed

About

Antje Wick is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Antje Wick has authored 87 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Genetics, 26 papers in Pulmonary and Respiratory Medicine and 24 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Antje Wick's work include Glioma Diagnosis and Treatment (68 papers), Brain Metastases and Treatment (20 papers) and MRI in cancer diagnosis (12 papers). Antje Wick is often cited by papers focused on Glioma Diagnosis and Treatment (68 papers), Brain Metastases and Treatment (20 papers) and MRI in cancer diagnosis (12 papers). Antje Wick collaborates with scholars based in Germany, United States and Switzerland. Antje Wick's co-authors include Wolfgang Wick, Michael Weller, Martin Bendszus, Philipp Kickingereder, David Bonekamp, Alexander Radbruch, Klaus Maier‐Hein, David A. Reardon, Alba A. Brandes and Surasak Phuphanich and has published in prestigious journals such as Journal of Clinical Oncology, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Antje Wick

83 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma

2020 946 citations Alba A. Brandes, Paul Mulholland et al. profile →
Automated brain extraction of multisequence MRI using artificial neural networks

2019 364 citations Fabian Isensee, Marianne Schell et al. profile →
Radiomic Profiling of Glioblastoma: Identifying an Imaging Predictor of Patient Survival with Improved Performance over Established Clinical and Radiologic Risk Models

2016 321 citations Philipp Kickingereder, Sina Burth et al. Radiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Antje Wick Germany	32	2.7k	1.5k	1.1k	994	975	87	4.6k
Seok‐Gu Kang South Korea	43	2.7k 1.0×	1.4k 0.9×	1.1k 1.0×	1.8k 1.8×	817 0.8×	211	6.2k
Oliver Schnell Germany	31	2.0k 0.7×	949 0.6×	523 0.5×	1.1k 1.1×	705 0.7×	118	3.8k
Elizabeth R. Gerstner United States	41	3.0k 1.1×	1.6k 1.1×	1.0k 1.0×	1.3k 1.4×	1.0k 1.1×	147	5.9k
Nicholas Butowski United States	41	3.5k 1.3×	885 0.6×	1.4k 1.3×	2.0k 2.0×	1.3k 1.4×	188	6.3k
Ghazaleh Tabatabai Germany	38	2.7k 1.0×	820 0.6×	836 0.8×	1.9k 1.9×	926 0.9×	183	5.3k
Bianca Pollo Italy	42	2.5k 0.9×	511 0.3×	1.3k 1.2×	1.9k 1.9×	685 0.7×	167	5.4k
Georg Widhalm Austria	40	2.7k 1.0×	844 0.6×	1.6k 1.5×	759 0.8×	2.0k 2.1×	213	5.7k
Jennifer Clarke United States	42	2.5k 0.9×	731 0.5×	1.4k 1.4×	1.2k 1.2×	1.8k 1.9×	175	5.7k
Surasak Phuphanich United States	34	2.7k 1.0×	525 0.4×	1.7k 1.7×	1.4k 1.4×	1.3k 1.3×	105	5.4k
Alicia Tosoni Italy	29	2.9k 1.1×	799 0.5×	771 0.7×	1.1k 1.1×	1.3k 1.3×	103	4.2k

Countries citing papers authored by Antje Wick

Since Specialization

Citations

This map shows the geographic impact of Antje Wick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antje Wick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antje Wick more than expected).

Fields of papers citing papers by Antje Wick

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antje Wick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antje Wick. The network helps show where Antje Wick may publish in the future.

Co-authorship network of co-authors of Antje Wick

This figure shows the co-authorship network connecting the top 25 collaborators of Antje Wick. A scholar is included among the top collaborators of Antje Wick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antje Wick. Antje Wick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burghaus, Ina, Tobias Keßler, Felix Sahm, et al.. (2024). PerSurge (NOA-30) phase II trial of perampanel treatment around surgery in patients with progressive glioblastoma. BMC Cancer. 24(1). 135–135. 26 indexed citations

Wick, Wolfgang, Antje Wick, Inga Harting, et al.. (2024). CTNI-85. FINAL RESULTS FROM N2M2/NOA-20. Neuro-Oncology. 26(Supplement_8). viii117–viii117.

Lopez, Juanita, Simon Haefliger, Ruth Plummer, et al.. (2023). Lisavanbulin in patients with recurrent glioblastoma: Phase 2a results and a consolidated analysis of response-predictive biomarkers.. Journal of Clinical Oncology. 41(16_suppl). 2044–2044. 1 indexed citations

Paech, Daniel, Johannes Breitling, Katerina Deike‐Hofmann, et al.. (2023). Whole-Brain Intracellular pH Mapping of Gliomas Using High-Resolution ³¹P MR Spectroscopic Imaging at 7.0 T. Radiology Imaging Cancer. 6(1). e220127–e220127. 6 indexed citations

Keßler, Tobias, Daniel Schrimpf, Leon D. Kaulen, et al.. (2023). Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial. Clinical Cancer Research. 29(19). 3892–3900. 11 indexed citations

Deimling, Andreas von, Antje Wick, Laila König, et al.. (2023). Isocitrate-dehydrogenase-mutant lower grade glioma in elderly patients: treatment and outcome in a molecularly characterized contemporary cohort. Journal of Neuro-Oncology. 161(3). 605–615. 2 indexed citations

Wick, Antje, Anja Sander, Matthew J. Koch, et al.. (2022). Improvement of functional outcome for patients with newly diagnosed grade 2 or 3 gliomas with co-deletion of 1p/19q – IMPROVE CODEL: the NOA-18 trial. BMC Cancer. 22(1). 645–645. 6 indexed citations

Seliger, Corinna, et al.. (2022). Lung toxicity of lomustine in the treatment of progressive gliomas. Neuro-Oncology Advances. 4(1). vdac068–vdac068. 8 indexed citations

Paech, Daniel, Armin M. Nagel, Reiner Umathum, et al.. (2020). Quantitative Dynamic Oxygen 17 MRI at 7.0 T for the Cerebral Oxygen Metabolism in Glioma. Radiology. 295(1). 181–189. 34 indexed citations

10.

Schell, Marianne, Gianluca Brugnara, Fabian Isensee, et al.. (2020). Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial. Neuro-Oncology. 22(11). 1667–1676. 9 indexed citations

11.

Keßler, Tobias, Anne Berberich, Ahmed Sadik, et al.. (2020). Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes. Cancer Medicine. 9(22). 8373–8385. 14 indexed citations

12.

Schubert, Maria‐Luisa, Alexander Kunz, Anita Schmitt, et al.. (2020). Assessment of CAR T Cell Frequencies in Axicabtagene Ciloleucel and Tisagenlecleucel Patients Using Duplex Quantitative PCR. Cancers. 12(10). 2820–2820. 14 indexed citations

13.

Bent, Martin J. van den, Martin Klein, Marion Smits, et al.. (2018). Bevacizumab and temozolomide in patients with first recurrence of WHO grade II and III glioma, without 1p/19q co-deletion (TAVAREC): a randomised controlled phase 2 EORTC trial. The Lancet Oncology. 19(9). 1170–1179. 82 indexed citations

14.

Wick, Wolfgang, Matthias Osswald, Antje Wick, & Frank Winkler. (2018). Treatment of glioblastoma in adults. Therapeutic Advances in Neurological Disorders. 11. 1277012020–1277012020. 102 indexed citations

15.

Wick, Wolfgang, Antje Wick, Martha Nowosielski, et al.. (2017). VXM01 phase I study in patients with resectable progression of a glioblastoma.. Journal of Clinical Oncology. 35(15_suppl). 2061–2061. 4 indexed citations

16.

Kickingereder, Philipp, Michael Götz, John Muschelli, et al.. (2016). Large-scale Radiomic Profiling of Recurrent Glioblastoma Identifies an Imaging Predictor for Stratifying Anti-Angiogenic Treatment Response. Clinical Cancer Research. 22(23). 5765–5771. 206 indexed citations

17.

Kickingereder, Philipp, David Bonekamp, Martha Nowosielski, et al.. (2016). Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features. Radiology. 281(3). 907–918. 229 indexed citations

18.

Kickingereder, Philipp, Alexander Radbruch, Sina Burth, et al.. (2016). MR-perfusion derived hemodynamic parametric response mapping of bevacizumab efficacy in recurrent glioblastoma. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 188(S 01). 1 indexed citations

19.

Hodapp, Volker, et al.. (1997). Ärger und Suizidrisiko. Der Nervenarzt. 68(1). 55–61. 5 indexed citations

20.

Hodapp, Volker, et al.. (1997). Ärger und Suizidrisiko Untersuchung an älteren psychiatrischen Patienten. Der Nervenarzt. 68(1). 55–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact